Try our Advanced Search for more refined results
Amicus Therapeutics Inc.
-
Order | Filed: April 12, 2024 | Entered: April 12, 2024 Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Oral Order
ORAL ORDER: The Court today has entered the parties' proposed stipulated orders regarding the case and its schedule. (D.I. 135; D.I. 136) It notes that the number of patents at issue in this case is large, and the parties' stipulation at D.I. 135 is long and a bit confusing. The Court's interest is in making sure that we move the case forward in a fair and expeditious manner such that we can have a trial on a manageable number of patents/issues/claims in June 2025. To the extent that, in the future, the parties believe that the Court should take further action to promote trial efficiency, they may feel free to reach out to the Court by way of motion or otherwise in that regard. Ordered by Judge Christopher J. Burke on 4/12/2024. (dlb)
-
Order | Filed: April 12, 2024 | Entered: April 12, 2024 Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
SO ORDERED Set/Reset Scheduling Order Deadlines
SO ORDERED D.I. 136 Stipulation To Amend Scheduling Order filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Reset Scheduling Order Deadlines: A Pretrial Conference is set for 6/6/2024 at 11:00 AM in Courtroom 2A before Judge Christopher J. Burke, Fact Discovery completed by 9/5/2024, Opening Expert Reports due by 10/31/2024, Rebuttal Expert Reports due by 12/19/2024, Expert Discovery due by 3/20/2025, Daubert Motions due by 4/24/2025, A 5-day Bench Trial is set for 6/23/2025 at 09:00 AM in Courtroom 2A before Judge Christopher J. Burke. Please see stipulation for further details and deadlines. Signed by Judge Christopher J. Burke on 4/12/2024. (dlb)
-
Order | Filed: April 12, 2024 | Entered: April 12, 2024 Amicus Therapeutics US, LLC et al v. Teva Pharmaceuticals USA, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
SO ORDERED
SO ORDERED D.I. 135 Stipulation Regarding Patents Asserted After June 8, 2023 filed by Amicus Therapeutics, Inc., Amicus Therapeutics US, LLC. Ordered by Judge Christopher J. Burke on 4/12/2024. (dlb)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login